A variety of age pigment-like fluorophores have been recognized, identified and investigated during the past three decades. They are mainly the end-products of various side-reactions of essential biological processes. Among these, the lipid peroxidation-related fluorophores formed via aldehyde-protein crosslinking are of general importance. Fluorescent advanced glycation end-products formed during glycation/Maillard reactions, are oxygen independent, carbohydrate-associated age pigment-like substances. Age pigments, particularly those identified in retinal pigment epithelium, represent another type of age pigment that originates from polyenic biomolecules, including retinoids and carotenoids. Various αβ-unsaturated aldehydes can also react with the amino groups of nucleotides to induce biological alteration. Although age pigments can be produced from different types of biological materials, the crosslinking of carbonyl and amino compounds is a common toxiferous process during biological life. In the context of various aging phenomena and degenerative diseases, this process may constitute an essential mechanism of aging --- the carbonyl toxification process of biological aging.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.